<?xml version="1.0" encoding="UTF-8"?>
<p>All samples that were positive for RVFV antibodies by the cELISA kit were analyzed by PRNT
 <sub>80</sub>. The PRNT
 <sub>80</sub> protocol used was adopted as previously described [
 <xref rid="pntd.0006931.ref022" ref-type="bibr">22</xref>]. The RVFV MP-12 vaccine strain, propagated in Vero-E6 cells, was used in the PRNT assay.
</p>
